Acta Scientific Gastrointestinal Disorders

Case Report Volume 8 Issue 11

An Exceptional Case of Budd-Chiari Syndrome Secondary to a Hepatic Hydatid Cyst

Abderrazzak Ajertil¹*, Fatine El Graoui², Youssef Mahdi³, Najat Kabbaj¹ and Mohamed Cherkaoui Malki1

1Department of Radiology, Cheikh Zaid International University Hospital, Rabat, Morocco
²Department of Gastroenterology, Cheikh Zaid International University Hospital, Rabat, Morocco
³Department of Intensive Care, Cheikh Zaid International University Hospital, Rabat, Morocco

*Corresponding Author: Abderrazzak Ajertil, Department of Radiology, Cheikh Zaid International University Hospital, UIASS, Rabat, Morocco.

Received: September 19, 2025; Published: October 25, 2025

Abstract

Budd-Chiari syndrome (BCS) is an uncommon but serious disorder caused by hepatic venous outflow obstruction, leading to hepatomegaly, ascites, portal hypertension, and liver failure. Secondary forms of BCS due to extraluminal compression from space-occupying lesions such as tumors, abscesses, or hydatid cysts are particularly rare.
We report the case of a 56-year-old woman with no prior comorbidities who presented with abdominal pain, ascites, and dyspnea. Imaging and serology revealed a large hepatic hydatid cyst causing compression and collapse of the retrohepatic inferior vena cava (IVC) and hepatic veins, leading to secondary BCS. She received conservative management with albendazole and anticoagulation, but declined surgical cyst resection. Unfortunately, she experienced a sudden cardiorespiratory arrest three weeks after discharge, most likely due to complications of the cyst such as rupture with anaphylaxis or cardiac compression.
This case highlights the importance of considering hydatid cysts in the differential diagnosis of BCS, especially in endemic regions, and emphasizes early recognition and appropriate management to prevent fatal outcomes.

Keywords: Budd-Chiari Syndrome; Hepatic Venous Outflow Obstruction; Echinococcus granulosus; Hydatid Cyst; Inferior Vena Cava Compression

References

  1. Bansal V., et al. “Budd-Chiari syndrome: imaging review”. British Journal of Radiology1088 (2018): 20180441.
  2. Janssen HL., et al. “Budd-Chiari syndrome: a review by an expert panel”. Journal of Hepatology 3 (2003): 364-371.
  3. Aydinli M and Bayraktar Y. “Budd-Chiari syndrome: etiology, pathogenesis and diagnosis”. World Journal of Gastroenterology19 (2007): 2693-2696.
  4. Agudelo Higuita NI., et al. “Cystic echinococcosis”. Journal of Clinical Microbiology3 (2016): 518-523.
  5. Khalili N., et al. “Hydatid disease: a pictorial review of uncommon locations”. Iranian Journal of Medical Sciences 2 (2023): 118-129.
  6. Laasri K., et al. “Hydatid cyst of the liver invading the inferior vena cava”. Radiology Case Report10 (2023): 4341-4344.
  7. Alghofaily KA., et al. “Hepatic hydatid disease complications: review of imaging findings and clinical implications”. Abdominal Radiology (NY)1 (2017): 199-210.
  8. Long J., et al. “Acute Budd-Chiari syndrome due to a simple liver cyst”. Annals of The Royal College of Surgeons of England 2 (2014): 109-111.
  9. Okuda K., et al. “Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion”. Hepatology5 (1998): 1191-1198.
  10. Manzano-Román R., et al. “Diagnostic and follow-up tools for human cystic echinococcosis: a new hope for the future”. Biomed Research International 2015 (2015): 428205.
  11. Ferrer Inaebnit E., et al. “Diagnosis and management of hepatic hydatid cyst”. Revista Española de Enfermedades Digestivas 1 (2022): 35-41.
  12. Gil-Grande LA., et al. “Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease”. Lancet8882 (1993): 1269-1272.

Citation

Citation: Abderrazzak Ajertil., et al. “An Exceptional Case of Budd-Chiari Syndrome Secondary to a Hepatic Hydatid Cyst".Acta Scientific Gastrointestinal Disorders 8.11 (2025): 03-06.

Copyright

Copyright: © 2025 Abderrazzak Ajertil., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In




News and Events


Contact US